Clinical Trials on Adenaocortical Carcinoma

Total 23754 results

Universitätsklinikum Hamburg-Eppendorf

Completed

Esophagogastrectomy Versus Extended Gastrectomy in AEG II (AEG-II-EG)

Carcinomas of the Esophagogastric Junction

Germany
National Cancer Institute (NCI)

Completed

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Recurrent Prostate Cancer | Fallopian Tube Cancer | Bone Metastases | Lung Metastases | Stage III Renal Cell Cancer | Liver Metastases | Recurrent Thyroid Cancer | Stage IV Follicular Thyroid Cancer | Stage IV Papillary Thyroid Cancer | Inflammatory Breast Cancer | Metastatic Transitional Cell Cancer of the... and other conditions

United States
Zhe Meng

Recruiting

A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery

Primary Aldosteronism | Cushing Syndrome | Nonfunctional Adrenal Cortex Adenoma

China
Brigham and Women's Hospital

Recruiting

Cardiovascular Manifestations of MR Activation in Primary Aldosteronism: Pilot Clinical Study

Hypertension | Primary Aldosteronism

United States
Tampere University Hospital
Helsinki University Central Hospital; Kuopio University Hospital; Tampere University

Completed

Renal Cysts and Primary Aldosteronism

Primary Aldosteronism

Finland
Umeå University

Unknown

Liquorice and Salivary Cortisol

Cushing Syndrome | Hypercortisolism

Sweden
Third Military Medical University

Recruiting

The Predictive Value of 24-hour Urinary Aldosterone on Target Organ Damage

Hypertension | Primary Aldosteronism

China
National Cancer Institute (NCI)

Completed

Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma

Lung Carcinoid Tumor | Metastatic Digestive System Neuroendocrine Tumor G1 | Paraganglioma | Pancreatic Polypeptide Tumor | Pancreatic Glucagonoma | Pancreatic Insulinoma | Recurrent Merkel Cell Carcinoma | Somatostatin-Producing Neuroendocrine Tumor | Stage IV Merkel Cell Carcinoma | Recurrent Digestive... and other conditions

United States
CHU de Quebec-Universite Laval

Recruiting

Personalized PRRT of Neuroendocrine Tumors (P-PRRT)

Neuroendocrine Tumors | Carcinoma, Neuroendocrine | Carcinoid Tumor

Canada
Icahn School of Medicine at Mount Sinai

Completed

Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal Hypercortisolism

Mild Hypercortisolism

United States
Charles University, Czech Republic
University Hospital Hradec Kralove

Unknown

Influence of Synacthen Infusion on the Results of Adrenal Venous Sampling in Patient With Primary Aldosteronism (ISIRA)

Primary Aldosteronism

Czech Republic
City of Hope Medical Center
National Cancer Institute (NCI)

Withdrawn

Physical Activity Intervention Before and After Surgery in Older Adults With Lung Cancer and Their Family Caregivers

Lung Non-Small Cell Carcinoma | Lung Carcinoid Tumor | Caregiver | Lobectomy Patient
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease

Symptomatic Refractory Resistant Carcinoid Disease

United Kingdom, Belgium, Italy, Singapore, Austria, France, Israel, Sweden, Germany, Spain, Canada, Argentina, Poland, United States, Brazil, Norway
Assistance Publique Hopitaux De Marseille

Completed

Patient and Partner Perception After Remission of Cushing's Syndrome (CUSHING)

Hypercorticism

France
Erasmus Medical Center
Pfizer; Dutch Kidney Foundation

Unknown

Diagnostic Properties of Aldosterone-Renin Ratio in Primary Aldosteronism Among Hypertensives.

Hypertension | Hyperaldosteronism

Netherlands
H. Lee Moffitt Cancer Center and Research Institute
Pharmacyclics LLC.

Completed

Phase II Study of Ibrutinib in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors

Carcinoid Tumors | Pancreatic NET

United States
Queen Mary University of London

Active, not recruiting

Effect of a Proposed Cav1.3 Inhibitor in Primary Aldosteronism

Primary Aldosteronism | Endocrine Hypertension

United Kingdom
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Terminated

Bronchoscopic Laser Ablation of Peripheral Lung Tumors

Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Metastatic Lung Carcinoma | Stage IV Lung Cancer AJCC v8 | Lung Carcinoid Tumor

United States
National Institute of Diabetes and Digestive and...

Recruiting

Natural History of Familial Carcinoid Tumor

Carcinoid

United States
Jazz Pharmaceuticals

Completed

Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors (EMERGE-201) (EMERGE-201)

Advanced Solid Tumor | Metastatic Solid Tumor | Urothelial Cancer | Poorly Differentiated Neuroendocrine Carcinomas | Homologous Recombination Deficient-Positive Malignancies Agnostic

United States
Centre Oscar Lambret

Completed

Toxicities of Cervix and Corpus Uteri Carcinomas Treatment and Evaluation of Impact on Sexual Function (SEXUTOX)

Corpus Uteri Carcinoma

France
National Taiwan University Hospital

Unknown

The Therapeutic Effect of Bromocriptin in Patients With Primary Aldosteronism

Hypertension | Hyperaldosteronism

Taiwan
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Metastatic Skin Squamous Cell Carcinoma | Unresectable Solid Neoplasm | Metastatic Kidney Medullary Carcinoma | Metastatic Penile Carcinoma | Small Cell Carcinoma | Metastatic Adrenal Gland Pheochromocytoma | Stage IV Penile Cancer... and other conditions

United States
Nanfang Li

Enrolling by invitation

Effect of MRA on Cardiovascular Disease in Patients With Hypertension and Hyperaldosteronemia (EMRACHH)

Hypertension | Hyperaldosteronaemia

China
Novartis

Completed

Proof-of-concept for the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronism

Primary Hyperaldosteronism

France
Dana-Farber Cancer Institute
Eli Lilly and Company

Active, not recruiting

A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors

Carcinoid Tumors

United States
H. Lee Moffitt Cancer Center and Research Institute
Novartis Pharmaceuticals; RECORDATI GROUP

Completed

Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)

Neuroendocrine Tumors | Carcinoid Tumors

United States
University of Western Ontario, Canada

Terminated

Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion

Neuroendocrine Tumors | Carcinoid Tumors

Canada
GERCOR - Multidisciplinary Oncology Cooperative...
Pfizer; Ipsen

Unknown

A Study of Sunitinib Versus Placebo in Combination With Lanreotide in Patients With Progressive Advanced/Metastatic Midgut Carcinoid Tumors (SUNLAND)

Carcinoid Tumors

France, Belgium
University of Erlangen-Nürnberg Medical School

Recruiting

Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy (ST-ICI02)

Renal Cell Carcinoma | Esophageal Cancer | NSCLC | Urothelial Carcinoma | HNSCC | Squamous Cell Carcinoma of the Skin | Small Cell Bronchial Carcinomas

Germany
University Hospital Padova
DMG Paris Descartes

Unknown

Macrolides for KCNJ5 - Mutated Aldosterone-Producing Adenoma (MAPA) (MAPA)

Hyperaldosteronism

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Lenvatinib in Recurrent and/or Metastatic Adenoid Cystic Carcinomas of the Salivary Glands: ACC-LEN14 (ACC-LEN14)

Adenoid Cystic Carcinomas of the Salivary Glands

Italy
Mayo Clinic
National Cancer Institute (NCI)

Completed

Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors

Breast Cancer | Colorectal Cancer | Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Adrenocortical Carcinoma

United States
European Institute of Oncology

Recruiting

Early Identification of Cardiac Involvement in Patients With Carcinoid: Clinical and Prognostic Implications

Neuroendocrine Tumors

Italy
University of Chicago

Withdrawn

Telotristat Ethyl for Reducing Intraoperative Carcinoid Crisis in Patients With Neuroendocrine Tumors

Neuroendocrine Tumors
Centre Hospitalier Universitaire Vaudois

Recruiting

Real-time Monitoring of Cortisol - Comparison of Cortisol Levels in Four Biological Fluids (SensoCort)

Hyperaldosteronism | Cushing Syndrome | Adrenal Insufficiency

Switzerland
Shaare Zedek Medical Center

Unknown

Does Aldosterone Cause Hypertension by a Non-Renal Mechanism?

Hypertension | Hyperaldosteronism | Dialysis

Israel
M.D. Anderson Cancer Center

Active, not recruiting

Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer

Lung Non-Small Cell Squamous Carcinoma | Stage IIA Lung Cancer AJCC v8 | Neuroendocrine Carcinoma | Lung Atypical Carcinoid Tumor | Minimally Invasive Lung Adenocarcinoma | Lung Neuroendocrine Neoplasm | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage... and other conditions

United States
Toray Industries, Inc

Completed

A Study of TRK-950 in Patients With Advanced Solid Tumors

Cholangiocarcinoma | Colon Cancer | Locally Advanced or Metastatic Solid Carcinomas

France, United States
Molecular Insight Pharmaceuticals, Inc.

Completed

ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid

Pheochromocytoma | Paraganglioma | Carcinoid
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Recruiting

The Clinical Efficacy and Safety of Finerenone in the Treatment of Primary Aldosteronism

Primary Aldosteronism | Mineralocorticoid Receptor Antagonist | Finerenone

China
HRA Pharma

Recruiting

Observational Registry on Patients With Endogenous CS to Document Safety and Effectiveness of Ketoconazole. (KetoPASS)

Cushing Syndrome

Sweden, France, Croatia, Spain
RECORDATI GROUP

Completed

Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699

Cushing's Syndrome

United States, Spain, Korea, Republic of, Canada, India, Thailand, China, Netherlands, France, Turkey, Japan, Brazil, Poland, Argentina, Austria, Belgium, Bulgaria, Costa Rica, Germany, Italy, Russian Federation
Corcept Therapeutics

Completed

Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants

Neoplasms | Cushing Syndrome

United States
Eunice Kennedy Shriver National Institute of Child...

Completed

Diagnostic Performance of Screening Tests for Cushing s Syndrome

Cushing's Syndrome

United States
Corcept Therapeutics

Completed

Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery

Cushing's Syndrome

United States
University Hospital, Toulouse

Completed

Arterial Stiffness Index as a Predictor of Surgically Correctable Primary Aldosteronism

Adenoma

France
Brigham and Women's Hospital

Recruiting

MR Antagonist and LSD1

Hypertension | Mineralocorticoid Excess

United States
HRA Pharma

Completed

Effects of Metyrapone in Patients With Endogenous Cushing's Syndrome (PROMPT)

Cushing's Syndrome

Germany, Belgium, Italy, Hungary, Poland, Romania, Spain, Turkey
National Center for Research Resources (NCRR)
University of Michigan

Completed

Hippocampal Complex Volume and Memory Dysfunction in Cushing's Syndrome

Cushing's Syndrome

United States

Clinical Trials on Adenaocortical Carcinoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations